Vaishali Pharma Limited - Asset Resilience Ratio

Latest as of September 2025: 25.30%

Vaishali Pharma Limited (VAISHALI) has an Asset Resilience Ratio of 25.30% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See VAISHALI working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rs308.48 Million
≈ $3.34 Million USD Cash + Short-term Investments

Total Assets

Rs1.22 Billion
≈ $13.19 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Vaishali Pharma Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see VAISHALI total asset value.

Liquid Assets Composition Over Time

This chart breaks down Vaishali Pharma Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Vaishali Pharma Limited total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs10.46 Million 0.86%
Short-term Investments Rs298.02 Million 24.44%
Total Liquid Assets Rs308.48 Million 25.30%

Asset Resilience Insights

  • Very High Liquidity: Vaishali Pharma Limited maintains exceptional liquid asset reserves at 25.30% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Vaishali Pharma Limited Industry Peers by Asset Resilience Ratio

Compare Vaishali Pharma Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Drug Manufacturers - Specialty & Generic 1.54%
Yunnan Baiyao Group Co Ltd
SHE:000538
Drug Manufacturers - Specialty & Generic 8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
Drug Manufacturers - Specialty & Generic 6.62%
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Harbin Gloria Pharmaceuticals
SHE:002437
Drug Manufacturers - Specialty & Generic 9.04%
Jiuzhitang Co Ltd
SHE:000989
Drug Manufacturers - Specialty & Generic 7.86%
Renhe Pharmacy Co Ltd
SHE:000650
Drug Manufacturers - Specialty & Generic 37.54%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%

Annual Asset Resilience Ratio for Vaishali Pharma Limited (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Vaishali Pharma Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 27.42% Rs301.23 Million
≈ $3.26 Million
Rs1.10 Billion
≈ $11.88 Million
+25.11pp
2024-03-31 2.31% Rs18.50 Million
≈ $200.09K
Rs799.56 Million
≈ $8.65 Million
-14.01pp
2023-03-31 16.32% Rs128.79 Million
≈ $1.39 Million
Rs789.07 Million
≈ $8.53 Million
+0.13pp
2022-03-31 16.19% Rs132.16 Million
≈ $1.43 Million
Rs816.24 Million
≈ $8.83 Million
+1.93pp
2021-03-31 14.26% Rs122.79 Million
≈ $1.33 Million
Rs861.23 Million
≈ $9.31 Million
+16.90pp
2020-03-31 -2.64% Rs-17.50 Million
≈ $-189.22K
Rs662.04 Million
≈ $7.16 Million
+1.58pp
2019-03-31 -4.22% Rs-29.00 Million
≈ $-313.66K
Rs687.51 Million
≈ $7.44 Million
-19.56pp
2018-03-31 15.34% Rs98.66 Million
≈ $1.07 Million
Rs643.23 Million
≈ $6.96 Million
+15.78pp
2017-03-31 -0.44% Rs-1.98 Million
≈ $-21.40K
Rs446.49 Million
≈ $4.83 Million
-1.02pp
2016-03-31 0.58% Rs2.88 Million
≈ $31.16K
Rs497.73 Million
≈ $5.38 Million
--
pp = percentage points

About Vaishali Pharma Limited

NSE:VAISHALI India Drug Manufacturers - Specialty & Generic
Market Cap
$12.40 Million
Rs1.15 Billion INR
Market Cap Rank
#26589 Global
#1471 in India
Share Price
Rs8.79
Change (1 day)
+0.11%
52-Week Range
Rs4.88 - Rs12.11
All Time High
Rs42.57
About

Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers a portfolio of active pharmaceutical ingredients, such as antibiotics, anti-ulcer, anti-inflammatory, analgesic, anti-pyretic, topical steroids, anti"malarial, cardiac, corticosteroids, anti-diabetics, anti-cold, anti-allergic, anti-diarrheal, anti-protozoal, anti-parasitic, excipients, anti-vir… Read more